Cargando…

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation

Epidermal Growth Factor Receptor (EGFR) is frequently over-expressed in head and neck squamous cell carcinoma (HNSCC) where aberrant signaling downstream of this receptor contributes to tumor growth. EGFR variant III (EGFRvIII) is the most commonly altered form of EGFR and contains a truncated ligan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Shinsuke, Morgan, Sarah E., Thomas, Sufi M., Sen, Malabika, Leeman-Neill, Rebecca J., Kuan, Chien-Tsun, Bigner, Darrell, Gooding, William E., Lai, Stephen Y., Grandis, Jennifer R.
Formato:	Texto
Lenguaje:	English
Publicado:	2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940981/ https://www.ncbi.nlm.nih.gov/pubmed/20622897 http://dx.doi.org/10.1038/onc.2009.279

Ejemplares similares

Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer
por: Peyser, Noah D., et al.
Publicado: (2016)

Nucleic acid-based approaches to STAT inhibition
por: Sen, Malabika, et al.
Publicado: (2012)

Nucleic Acid Targeting: Towards Personalized Therapy for Head and Neck Cancer
por: Parsel, Sean M, et al.
Publicado: (2015)

JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth()()
por: Sen, Malabika, et al.
Publicado: (2015)

Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
por: Peyser, Noah D., et al.
Publicado: (2015)

Challenges in EGFRvIII Detection in Head and Neck Squamous Cell Carcinoma
por: Wheeler, Sarah E., et al.
Publicado: (2015)

STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors
por: Ramasamy, Thiruganesh, et al.
Publicado: (2020)

Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer
por: Peyser, Noah D., et al.
Publicado: (2015)

STAT3 Oligonucleotide Inhibits Tumor Angiogenesis in Preclinical Models of Squamous Cell Carcinoma
por: Klein, Jonah D., et al.
Publicado: (2014)

Activated HGF-c-Met Axis in Head and Neck Cancer
por: Arnold, Levi, et al.
Publicado: (2017)

Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma
por: Zhang, Liyong, et al.
Publicado: (2018)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)

Antitumor efficacy of D2C7-(scdsFv)-PE38KDEL, a novel immunotoxin targeting EGFRwt and EGFRvIII, by convection-enhanced delivery in orthotopic brain tumor mouse models
por: Bao, Xuhui, et al.
Publicado: (2013)

Anatomy (Head and Neck). PART III
Publicado: (1941)

Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation
por: Koch, Dominik Thomas, et al.
Publicado: (2017)

Quantitative clinical outcomes of therapy for head and neck lymphedema
por: Doke, Kaleigh N., et al.
Publicado: (2018)

Ultrasound Targeted Microbubble Destruction-Mediated Delivery of a Transcription Factor Decoy Inhibits STAT3 Signaling and Tumor Growth
por: Kopechek, Jonathan A., et al.
Publicado: (2015)

SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer
por: Zhou, Z, et al.
Publicado: (2016)

Radiosensitization of head and neck cancer by targeting the epidermal growth factor receptor
por: Goel, Arun Kumar, et al.
Publicado: (2009)

Toxic epidermal necrolysis associated with nivolumab treatment for head and neck cancer
por: Koshizuka, Keiichi, et al.
Publicado: (2020)

Head and Neck Cancer among American Indian and Alaska Native Populations in California, 2009–2018
por: Warren, Brooke R., et al.
Publicado: (2021)

Adaptive radiotherapy for head and neck cancer
por: Morgan, Howard E., et al.
Publicado: (2020)

Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts
por: Lee, Rex H., et al.
Publicado: (2023)

Targeting the JAK/STAT pathway in solid tumors
por: Qureshy, Zoya, et al.
Publicado: (2020)

Prognostic Worth of Epidermal Growth Factor Receptor (EGFR) in Patients with Head and Neck Tumors
por: Barnes, Precious, et al.
Publicado: (2020)

Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor
por: Singh, Tripti, et al.
Publicado: (2015)

Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
por: Li, Rui, et al.
Publicado: (2013)

Identification of Mutations in the PYRIN-Containing NLR Genes (NLRP) in Head and Neck Squamous Cell Carcinoma
por: Lei, Yu, et al.
Publicado: (2014)

Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors
por: Egloff, Ann Marie, et al.
Publicado: (2009)

Lymph node ratio as a prognostic factor in head and neck cancer patients
por: Chen, Chien-Chih, et al.
Publicado: (2015)

Multiple phenotypic changes in mice after knockout of the B3gnt5 gene, encoding Lc3 synthase--a key enzyme in lacto-neolacto ganglioside synthesis
por: Kuan, Chien-Tsun, et al.
Publicado: (2010)

The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications
por: Zimmermann, Michel, et al.
Publicado: (2006)

Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells
por: Dawson, John C., et al.
Publicado: (2011)

The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck
por: Russell, Jeffery S., et al.
Publicado: (2012)

NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models
por: Li, Hua, et al.
Publicado: (2022)

Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2016)

Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status
por: Hofman, P, et al.
Publicado: (2008)

Otolaryngology, Head and Neck Surgery
por: Yang, Tsung-Lin, et al.
Publicado: (2014)

Targeting STAT3 in Cancer with Nucleotide Therapeutics
por: K. Lau, Yue-Ting, et al.
Publicado: (2019)

Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines
por: Stegeman, Hanneke, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n19h2hb7pd0uje4mnp79moo4lg